Cargando…

Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations


Despite effective pharmacological treatments for psychotic symptoms (eg, hallucinations, delusions), functional outcomes for people with psychotic disorders are often disappointing. Although it is not included in the diagnostic criteria for psychotic disorders, cognitive impairment is one of the str...

Descripción completa

Detalles Bibliográficos
Autores principales: McCleery, Amanda, Nuechterlein, Keith H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Les Laboratoires Servier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829172/
https://www.ncbi.nlm.nih.gov/pubmed/31749648
http://dx.doi.org/10.31887/DCNS.2019.21.3/amccleery
_version_ 1783465491624361984
author McCleery, Amanda
Nuechterlein, Keith H.
author_facet McCleery, Amanda
Nuechterlein, Keith H.
author_sort McCleery, Amanda
collection PubMed
description Despite effective pharmacological treatments for psychotic symptoms (eg, hallucinations, delusions), functional outcomes for people with psychotic disorders are often disappointing. Although it is not included in the diagnostic criteria for psychotic disorders, cognitive impairment is one of the strongest determinants of community functioning in this clinical population, and thus it is an important target for intervention. In this review, we discuss the major areas of research regarding impaired cognition in psychotic illness. The specific topics covered include: (i) the prevalence of cognitive impairment in psychotic disorders; (ii) the profile and magnitude of cognitive impairment in psychotic disorders; (iii) the developmental course of cognitive impairment; (iv) the longitudinal stability of cognitive impairment; and (v) treatment approaches to improve cognitive performance in people with psychotic disorders.

format Online
Article
Text
id pubmed-6829172
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Les Laboratoires Servier
record_format MEDLINE/PubMed
spelling pubmed-68291722019-11-20 Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations
 McCleery, Amanda Nuechterlein, Keith H. Dialogues Clin Neurosci Original Article Despite effective pharmacological treatments for psychotic symptoms (eg, hallucinations, delusions), functional outcomes for people with psychotic disorders are often disappointing. Although it is not included in the diagnostic criteria for psychotic disorders, cognitive impairment is one of the strongest determinants of community functioning in this clinical population, and thus it is an important target for intervention. In this review, we discuss the major areas of research regarding impaired cognition in psychotic illness. The specific topics covered include: (i) the prevalence of cognitive impairment in psychotic disorders; (ii) the profile and magnitude of cognitive impairment in psychotic disorders; (iii) the developmental course of cognitive impairment; (iv) the longitudinal stability of cognitive impairment; and (v) treatment approaches to improve cognitive performance in people with psychotic disorders.
 Les Laboratoires Servier 2019-09 /pmc/articles/PMC6829172/ /pubmed/31749648 http://dx.doi.org/10.31887/DCNS.2019.21.3/amccleery Text en © 2019, AICH – Servier GroupCopyright © 2019 AICH – Servier Group. All rights reserved http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
McCleery, Amanda
Nuechterlein, Keith H.
Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations

title Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations

title_full Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations

title_fullStr Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations

title_full_unstemmed Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations

title_short Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations

title_sort cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations

topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829172/
https://www.ncbi.nlm.nih.gov/pubmed/31749648
http://dx.doi.org/10.31887/DCNS.2019.21.3/amccleery
work_keys_str_mv AT mccleeryamanda cognitiveimpairmentinpsychoticillnessprevalenceprofileofimpairmentdevelopmentalcourseandtreatmentconsiderations
AT nuechterleinkeithh cognitiveimpairmentinpsychoticillnessprevalenceprofileofimpairmentdevelopmentalcourseandtreatmentconsiderations